Intrinsiqq
IM Cannabis Corp. logo

IM Cannabis Corp. Quality Score

IMCC

Compare
Quality30

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-0.2x

Negative earnings, no valuation support

Cash Flow Multiple
40/100
87.8x

Above 30x, cash flow yield is thin

Revenue Growth
0/100
-1.6%

Below 2%, essentially flat

Cash Flow Growth
60/100
Just turned +

Recently turned FCF-positive, capex cycle finishing, CAGR not yet meaningful

Business Quality & Capital Allocation

Share Dilution
0/100
249.2%

Heavy dilution above 5%

Margin Trend
100/100
+15.1pp

Expanded 3+pp, strong improvement

Capital Structure
0/100
C$14M

Net debt/FCF of 276.3x, high leverage

2022
C$2.00M
C$12.0M
2023
C$2.00M
C$14.0M
2024
C$863000
C$18.0M
2025
C$3.00M
C$16.0M
CashDebt
Return on Capital
0/100
-48.9%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

IM Cannabis (IMCC) quality: score, margins and returns

IM Cannabis (IMCC) scores 30/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on -26.4% operating margins and -48.9% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is IM Cannabis (IMCC) a high-quality business?+

IM Cannabis scores 30 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -26.4% operating margin and a -48.9% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does IM Cannabis's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from IMCC's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where IM Cannabis scores well and where it falls behind.

What is IM Cannabis's return on invested capital (ROIC)?+

IM Cannabis earns about -48.9% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to IMCC's margins and growth on this scorecard to judge durability.

How profitable is IM Cannabis?+

IM Cannabis runs an operating margin of about -26.4% and a net margin of about -28.3%. Revenue has grown at roughly 3.2% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with IMCC

CompareIntrinsic value
LIK.XETRLimes Schlosskliniken AG
€580.00-1.69%65
NORDH.XOSLNordhealth AS
€2.34-0.85%48
ALDMS.XPARDiagnostic Medical Systems S.A.
€0.89-0.67%30
ALEMS.XBRUEuropean Medical Solutions S.A.
€3.50+2.34%76
ENZY.XSTOEnzymatica AB
€0.18-4.59%25
SDOS.XSTOScandiDos AB
€0.01-20.00%25
7V0.XETRDarwin AG
€5.30+0.00%24
AJ91.XETRDocCheck AG
€10.10+0.00%58

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IMCC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.